Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Depreciation & Amortization (CF) (2019 - 2025)

Korro Bio (KRRO) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 25.67% year-over-year to $1.1 million, compared with a TTM value of $4.9 million through Sep 2025, up 51.12%, and an annual FY2024 reading of $3.6 million, changed 0.0% over the prior year.
  • Depreciation & Amortization (CF) was $1.1 million for Q3 2025 at Korro Bio, down from $1.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.3 million in Q2 2025 and bottomed at $382000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $825684.2, with a median of $737000.0 recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (CF) surged 277.46% in 2021, then plummeted 44.91% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $737000.0 in 2021, then plummeted by 44.91% to $406000.0 in 2022, then soared by 135.22% to $955000.0 in 2023, then soared by 34.87% to $1.3 million in 2024, then fell by 12.19% to $1.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for KRRO at $1.1 million in Q3 2025, $1.3 million in Q2 2025, and $1.2 million in Q1 2025.